Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a tiny epinephrine shot prevent dangerous drops in blood pressure during C-Sections?

NCT ID NCT07480889

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This study tests whether giving a small dose of epinephrine (adrenaline) right after spinal anesthesia, followed by a steady infusion, can prevent blood pressure drops during cesarean sections. Researchers will compare this approach to epinephrine infusion alone in 100 women aged 18-35. The goal is to see if the bolus provides better stability without increasing risks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Epinephrine (adrenaline)
What this could lead to
If successful, this could offer a simple way to prevent dangerous blood pressure drops during C-sections, improving safety for mothers.
What could go wrong
This is a small, early-phase trial with only 100 participants, so results may not apply to all patients. Epinephrine can cause side effects like rapid heart rate or high blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

80 people

The number who actually took part.

Started

Mar 2026

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age: 18 to 35 years. 2. American Society of Anesthesiologists (ASA) physical status II. 3. Undergoing Elective Lower Segment Cesarean Section under Spinal Anesthesia. Exclusion Criteria: 1. Uncontrolled cardiac morbidities as reduction of ejection fraction\< 60%, History (within 3months) of myocardial infarction, cerebrovascular accident, transient ischemic attacks or coronary artery disease/stents 2. Poorly controlled Hypertensive disorders of pregnancy 3. Peripartum bleeding 4. Multiple pregnancies (e.g., twin gestations) 5. Coagulation disorders defined as platelet count \<100,000/μL, INR \>1.4, or known inherited clotting factor deficiency. 6. Baseline systolic blood pressure (SBP) \< 100 mmHg or \>130 mmHg 7. Refusal of patients.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemodynamic (MAP) stability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemodynamic (MAP) stability

Contacts and locations

Locations

  • Kasr Alaini hospital

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.